Goldman Sachs Maintains Buy on Xylem, Lowers Price Target to $138
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Goldman Sachs analyst Brian Lee maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $160 to $138.
Goldman Sachs analyst Brian Lee maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $160 to $138.